Primary-care physicians | Hospital-care physicians | |
---|---|---|
Section 2 – Antibiotics and resistance | ||
Statement | ICC (95 % CI) | ICC (95 % CI) |
S 1: Antibiotic resistance is an important Public Health problem in our setting (Ignorance). | 0.873 (0.733; 0.940)*** | 0.711 (0.394; 0.863)*** |
S 2: In a primary-care context, one should wait for the microbiology results before treating an infectious disease (Ignorance). | 0.530 (0.013; 0.776)* | 0.751 (0.477; 0.882)*** |
S 3: Rapid and effective diagnostic techniques are required for diagnosis of infectious diseases (Responsibility of others – Health care System). | 0.542 (0.038; 0.782)* | 0.590 (0.138; 0.805)** |
S 4: The prescription of an antibiotic to a patient does not influence the possible appearance of resistance (Ignorance). | 0.432 (−0.193; 0.730) | 0.906 (0.801; 0.955)*** |
S 5: I am convinced that new antibiotics will be developed to solve the problem of resistance (Responsibility of others – Investigation) | 0.548 (0.050; 0.785)* | 0.922 (0.836; 0.963)*** |
S 6: The use of antibiotics on animals is an important cause of the appearance of new resistance to pathogenic agents in humans (Responsibility of others) | 0.858 (0.703; 0.933)*** | 0.509 (−0.031; 0.766)* |
S 7: In case of doubt, it is preferable to use a wide-spectrum antibiotic to ensure that the patient is cured of an infection (Fear). | 0.777 (0.532; 0.894)*** | 0.926 (0.845; 0.965)*** |
S 8: I frequently prescribe an antibiotic in situations in which it is impossible for me to conduct a systematic follow-up of the patient (Fear). | 0.666 (0.297; 0.841)** | 0.835 (0.653; 0.922)*** |
S 9: In situations of doubt as to whether a disease might be of bacterial aetiology, it is preferable to prescribe an antibiotic (Fear). | 0.402 (−0.256; 0.715) | 0.859 (0.704; 0.933)*** |
S 10: I frequently prescribe antibiotics because patients insist on it (Complacency). | 0.864 (0.715; 0.935)*** | 0.429 (−0.200; 0.728) |
S 11: I sometimes prescribe antibiotics so that patients continue to trust me (Complacency). | 0.857 (0.700; 0.932)*** | 0.855 (0.695; 0.931)*** |
S 12: I sometimes prescribe antibiotics, even when I know that they are not indicated because I do not have the time to explain to the patient the reason why they are not called for (Indifference). | 0.860 (0.705; 0.923)*** | 0.946 (0.887; 0.974)*** |
S 13: If a patient feels that he/she needs antibiotics, he/she will manage to obtain them at the pharmacy without a prescription, even when they have not been prescribed (Responsibility of others – Other Professionals). | 0.822 (0.625; 0.915)*** | 0.753 (0.481; 0.882)*** |
S 14: Two of the main causes of the appearance of antibiotic resistance are patient self-medication and antibiotic misuse (Responsibility of others – Patients). | 0.767 (0.510; 0.889)*** | 0.468 (−0.117; 0.747) |
S 15: Dispensing antibiotics without a prescription should be more closely controlled (Responsibility of others – Health care System). | 0.683 (0.325; 0.851)** | 0.692 (0.353; 0.853)** |
S 16: In a primary-care context, amoxicillin is useful for treating most respiratory infections (Ignorance). | 0.470 (−0.074; 0.748) | 0.745 (0.465; 0.879)*** |
S 17: The phenomenon of resistance to antibiotics is mainly a problem in hospital settings (Responsibility of others – Other Professionals). | 0.690 (0.348. 0.852)** | 0.706 (0.382; 0.860)** |
Section 3 – In the treatment of respiratory tract infections, how would you rate the usefulness of each of these sources of knowledge? | ||
Statement | ICC (95 % CI) | ICC (95 % CI) |
S 1’: Clinical practice guidelines. | 0.846 (0.676; 0.927)*** | 0.562 (0.079; 0.791)* |
S 2’: Documentation furnished by the Pharmaceutical Industry. | 0.579 (0.116; 0.800)* | 0.746 (0.467; 0.879)*** |
S 3’: Courses held by the Pharmaceutical Industry. | 0.519 (−0.011; 0.771)* | 0.734 (0.441; 0.873)*** |
S 4’: Information furnished by Medical Information Officers. | 0.851 (0.687; 0.929)*** | 0.753 (0.481; 0.883)*** |
S 5’: Previous clinical experience. | 0.715 (0.401; 0.864)*** | 0.714 (0.399; 0.864)** |
S 6’: Continuing Education Courses. | 0.708 (0.387; 0.861)*** | 0.797 (0.574; 0.904)*** |
S 7’: Others, e.g., contribution of specialists (microbiologists, infectious disease specialists, etc.). | 0.948 (0.890; 0.975)*** | 0.595 (0.148; 0.807)** |
S 8’: Contribution of peers (of the same specialisation). | 0.764 (0.505; 0.888)*** | 0.655 (0.275; 0.836)** |
S 9’: Data collected via the Internet. | 0.723 (0.419; 0.868)** | 0.762 (0.500; 0.887)*** |